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Abstract 
Objective:  To understand how consumers’ illness management and consumer-provider 
relationships are associated with shared decision-making.  
Methods: 79 consumers were audio-recorded in medication management 
appointments.  Shared decision-making and consumer-provider agreement on decisions 
were rated.  Mental health diagnoses, medication adherence, patient activation, illness 
management, working alliance, and length of consumer-provider relationships were all 
assessed. Correlation analyses were used to determine relationships among measures. 
Results:  Overall shared decision-making was not associated with any variables.  
Minimum levels of shared decision-making were associated with higher scores on the 
Bond subscale of the Working Alliance Inventory and higher medication adherence.  
Agreement was associated with shorter consumer-provider relationships. 
Conclusions:  The association between consumer-provider relationships and shared 
decision-making might be more nuanced than originally thought.   
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Shared decision-making is a process by which consumers and providers share 
information and opinions, talk about each other’s responsibilities, and ultimately agree 
on treatments (1).  Shared decision-making has been advocated because of its potential 
to increase evidence-based practices, decrease variations in healthcare delivery, and 
promote consumers’ involvement in care (2).  It is consistent with a consumer-centered, 
recovery-oriented mental health system where consumers are encouraged to actively 
engage in illness management (3).   
Recent frameworks have described the consumer-provider relationship and key 
features of a consumer’s illness management (e.g., activation, adherence) as integral to 
shared decision-making. This is particularly applicable in chronic conditions 
longitudinally managed with one’s provider (4, 5).  In this “expanded” model, the 
moment when a decision is deliberated is only part of the shared decision-making 
process. 
Despite the importance of shared decision-making in mental health, few studies 
have directly examined the process in mental health consultations. A recent study using 
an adaptation of Braddock’s decision-making scale found mental health medication 
consultations met minimum criteria for shared decision-making about half the time (6). 
Further examination of these data indicated when consumer participation and decision 
complexity increased, more shared decision-making occurred (7). While these studies 
add to our understanding of shared decision-making, critical questions remain 
unexplored. Especially for chronic conditions, recent models of shared decision-making 
have placed increased emphasis on factors such as a consumer’s illness management 
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and the consumer-provider relationship (4, 5).  Yet we know little about how these 
factors relate to observed decision-making. We hypothesized that greater shared 
decision-making would be observed when the consumer-provider relationship was 
stronger and consumers had better illness management skills.  
Methods 
This study took place in a psychiatric clinic at a Veterans Affairs medical center 
from January to September 2012.  The clinic has 23 providers, serving approximately 
5,200 veterans with diagnoses including PTSD, depression, and anxiety disorder.  Three 
providers were approached and agreed to participate in this study. All providers were 
female.  One was a psychiatrist; the others were advanced practice nurses.  Consumers 
were eligible for participation if they were seeing one of the three consenting providers 
during the study period and were not experiencing symptom exacerbations that 
concerned the provider.    
A research assistant explained the study to eligible consumers when they 
checked in with the clinic. Interested consumers completed an informed consent 
process. Consumers were told the study was about communication, but not of our 
interest in shared decision-making, to help ensure that participation did not alter 
natural decision-making in visits. 
For the appointment, the research assistant placed an audio recorder in the 
exam room and waited outside.  After the visit, consumers completed a series of 
questionnaires.  Consumers were paid $10 for the clinic visit and $20 to complete 
6 
questionnaires.  Providers were not paid.  All procedures were approved by the local 
Institutional Review Board and medical center review committee.   
We collected demographic information from consumer report and mental health 
diagnoses from medical records. Medication adherence was measured with the 10-item 
Medication Adherence Rating Scale (MARS).  The first four items (Morisky Scale) 
measure medication adherence behaviors; the last six measure attitudes and beliefs 
about medications.  The scale has adequate internal consistency, test-retest reliability, 
and high positive correlations with the Medication Adherence Questionnaire (r = .79) 
and the Drug Attitude Inventory (r = .82) (8). Lower values indicate higher self-reported 
adherence. 
Illness self-management was measured with the Illness Management and 
Recovery Scale (IMR Scale, Client Version), a 15-item questionnaire rated on a 5-point 
behaviorally-anchored scale.  Questions include items related to progress toward goals, 
knowledge about mental illness, involvement with significant others, symptom distress 
and coping, and alcohol and drug use.  The scale is internally consistent, with good test-
retest reliability and convergent validity (9). 
The Mental Health Version of the Patient Activation Measure (PAM-MH) was 
used to assess patient activation, i.e., the knowledge, skills, and confidence to manage 
illness (10).  The 13-item PAM-MH has been used in several studies of people with 
mental illness, and shows strong reliability and validity (10). Scores range from 0 to 100, 
with higher scores indicating greater activation. 
Length of consumer-provider relationship was measured through consumer self-
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report. The Working Alliance Inventory (WAI) was used to assess consumer-provider 
agreement on treatment goals, collaboration to achieve these goals, and degree of 
emotional bond (i.e., liking and trust) between consumers and providers (11). In its 
original development and validation, the WAI showed high reliability and demonstrated 
convergent, discriminant, concurrent, and predictive validity. We administered the short 
form (12 items) of the client version of the WAI and examined total scores and scores on 
three subscales:  task, bond, and goals.  
The Shared Decision-Making (SDM) Scale is adapted from Braddock’s Informed 
Decision-Making Scale, which has demonstrated high reliability in several studies of 
decision-making in primary care and surgery (1).  The scale has been shown to reliably 
assess shared decision-making in mental health consultations (6).  The scale is applied to 
transcripts of clinic visits by independent raters and identifies nine elements of shared 
decision-making (see Appendix). Items are summed for an overall score ranging from 0 
to 18.  Decisions are classified by complexity based on level of medical consensus and 
the extent to which the treatment decision’s consequences could affect the consumer’s 
life.  
Braddock et al. (1) described a minimum level of decision-making (SDM-Min), 
based on decision complexity. For basic decisions, SDM-Min criteria are element #3, 
discussion of the decision’s clinical nature, and either the consumer’s desired role in 
decision-making (#1) or consumer preference (#9).  Intermediate decisions require 
these elements plus discussion of alternatives (#4), pros/cons of decision (#5), and 
assessment of consumer understanding (#7). Complex decisions require all nine 
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elements.  Decisions were coded for agreement as follows:  full agreement, consumer or 
provider passively agrees, consumer or provider disagrees.  The latter two categories 
were collapsed into “lack of full agreement.”    
Transcripts were divided among four trained coders, who independently coded 
each transcript.  To ensure consistency, one of every 3 transcripts was independently 
coded by all coders, who then met to compare coding and reach consensus. We used 
overall scores, presence of minimum shared decision-making (SDM-Min: 0 [not present] 
vs. 1 [present]), and overall agreement (0 [lack of full agreement] vs. 1 [full agreement]). 
Correlation analyses (Pearson product-moment correlation for continuous 
measures and point-biserial correlation for dichotomous measures) were used to test 
the hypothesis that relationship factors (longer consumer-provider relationship, greater 
working alliance), and consumer self-management factors (greater medication 
adherence, illness management, and activation) would be related to greater shared 
decision-making, likelihood of minimum shared decision-making (SDM-Min) and 
consumer-provider agreement.   We did not adjust for multiple comparisons, since this 
can obscure potential findings in exploratory contexts (12).  We discuss results as 
statistically significant at p < .05.  SAS (v9.3) was used for analyses. 
Results 
One hundred-two consumers were approached; 79 (78%) participated.  Most 
common reasons for refusal were anxiety, lack of time, and lack of interest. Four were 
unable to stay after their appointment to complete the questionnaires and were 
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dropped from analysis.  Results are presented only for visits that included a treatment 
decision (i.e., discussion with explicit course of action, n=63).   
Consumers’ ages ranged from 23 to 71 years (M=53±10).  Nine (14%) were 
women; all were veterans.  Forty-seven (75%) were white; 13 (16%) African American, 2 
Hispanic, 1 American Indian. Primary diagnoses were anxiety disorder (including PTSD, 
56%), mood disorder (40%), schizophrenia spectrum (3%), and other (1%).  
Demographics were not significantly related to overall shared decision-making score, 
SDM-Min, or agreement. Consumer-provider relationship duration ranged from 2 
months to 10 years (M=29.8±25.8 mo.).  Shared decision-making scores ranged from 3 
to 13 (M=9.4±2.4).  About half met SDM-Min criteria (n=28, 44%). Fifty-five (87%) had 
full agreement; eight decisions (13%) had passive/reluctant agreement by consumers. 
Eighteen decisions (29%) were basic, 43 (68%) intermediate, and 2 (3%) complex.   
Measures had satisfactory internal reliability (α ≥ .73), with the exception of 
MARS total (α=.58) and the Goals subscale of Working Alliance Inventory (α=.53), which 
were dropped from analysis.  Cronbach’s alpha for the Morisky scale was .62. 
 Overall shared decision-making scores were not significantly associated with any 
measures (see Table).  SDM-Min was associated with the Bond subscale of the Working 
Alliance Inventory (r=.29, p<.05).   For those who met SDM-Min criteria, the mean Bond 
score was 25.9±2.2 compared to those without minimum shared decision-making 
(M=24.4±2.9).  Medication adherence (Morisky scale) was significantly associated with 
SDM-Min (r=-.32, p<.05), indicating that participants with SDM-Min were more likely to 
report taking medications as prescribed (M=.8±1.0) than those who did not meet SDM-
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Min criteria (M =1.5±1.2).    
Overall agreement was associated with a shorter consumer-provider relationship 
(r = -.31, p < .05).  Those with full agreement had been together for a mean of 26.8±22.8 
months, compared to those who did not fully agree (50.3±36.2).  Overall agreement was 
related to medication adherence in the expected direction (r=-.28 p<.05), but not to 
working alliance or other variables.  
Discussion 
This study examined associations between shared decision-making and factors 
related to illness management and the consumer-provider relationship. Contrary to our 
hypothesis, overall shared decision-making was not related to measured variables.  
However, minimum levels of shared decision making (SDM-Min) were associated with 
consumer-provider bond, measured by the Working Alliance Inventory.  Bond refers to 
liking and trust between consumers and providers.  Given that SDM-Min requires either 
discussion of the consumer’s role in decision-making or exploration of preferences, 
these positive feelings likely encourage such discussions.  Conversely, adopting a shared 
decision-making approach could lead to greater consumer-provider bond. Medication 
adherence was also significantly associated with SDM-Min, indicating a positive 
relationship between shared decision-making and taking medications as prescribed. This 
is consistent with other work showing shared decision-making to be associated with 
adherence (13).  Relatedly, the positive relationship between adherence and agreement 
on a decision is unsurprising, since agreeing on treatment decisions should lead to 
greater treatment adherence.   
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Minimum levels of shared decision-making (versus total score) may be more 
relevant for mental health, and, more generally, chronic illness management.  Because 
individuals with chronic conditions typically visit providers regularly, shared decision-
making often occurs over numerous visits--it may be unnecessary to revisit each 
element each time (5).  However, when treatment decisions are made, certain elements 
should still be discussed, which may be what SDM-Min is reflecting in this study.  
Overall decision agreement was associated with shorter consumer-provider 
relationships.  Initially, this appears counterintuitive—consumers and providers 
becoming more familiar over time with one another’s preferences and needs might 
have greater agreement. However, longer relationships might lead to participants 
feeling more comfortable expressing disagreement, rather than keeping silent.    
It was surprising that patient activation was not related to shared decision-
making.  Activated consumers take greater “ownership” of their health care, which 
should translate to greater involvement in treatment decisions.  However, a previous 
study also found no relationship between patient activation and observer-rated 
activation in mental health visits (14).  Activation might not manifest in communication, 
specifically decision-making, especially if consumers and providers have had a long 
relationship.    
This study is limited in that we only included three providers, and did not 
examine provider factors (e.g., years of experience, attitudes, gender) that might 
influence shared decision-making. Because all providers were female and most 
consumers were male, gender might have affected findings, particularly since research 
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indicates female patients are more involved in treatment and ask more questions (15). 
Second, insufficient statistical power might have obscured some relationships.  
However, many correlations were so low that greater power would have been unlikely 
to change results. Third, the cross-sectional study design does not facilitate causal 
claims.  Fourth, excluding consumers experiencing symptom exacerbations might have 
limited our ability to examine a wider range of decision-making, including the potential 
for greater provider paternalism.  Fifth, the small magnitude of some correlations may 
call into question the clinical significance of some associations among variables. More 
research is needed to better understand these relationships. Finally, this study was 
conducted at a single VA medical center.  There might be variations among different 
mental health clinics and differences between veterans and non-veterans.  
Conclusions 
This study adds to our knowledge of shared decision-making and suggests 
important directions for future research.  Specifically, the role of minimum levels of 
shared decision-making in chronic care, the influence of the consumer-provider 
relationship, and the role of patient activation in shared decision-making merit further 
investigation. Future research should further explore these factors while examining 
decision-making over multiple provider visits.  
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Table. Correlations among study variables 
   1 2 3 4 5 6 7 8 9 10 
1 SDM Tot 1.00          
2 SDM-Min .30* 1.00         
3 Agreement .01 .25 1.00        
4 Relationship Length .00 .00 -.31* 1.00       
5 IMR Scale -.05 -.04 .17 .06 1.00      
6 Morisky Scale  -.03 -.32* -.28* .09 -.10 1.00     
7 PAM-MH .03 -.09 .22 -.03 .52 *** -.25 1.00    
8 Wkg Alliance Total .07 .13 .13 -.04 .42 *** -.13 .23 1.00   
9 Task .04 .11 .19 -.02 .47*** -.08 .23 .92*** 1.00  
10 Bond .06 .29* .17 .09 .22 -.24 .18 .80*** .64*** 1.00 
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